Real-world data for tisagenlecleucel in patients with R/R B-ALL: subgroup analyses from the CIBMTR registry.
- DOI
- 10.1182/bloodadvances.2025015881
- Published
- 2025 Oct 28
- Container
- Blood advances
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1182/bloodadvances.2025015881,
title = {Real-world data for tisagenlecleucel in patients with R/R B-ALL: subgroup analyses from the CIBMTR registry.},
author = {John S and Curran KJ and Hall EM and Keating AK and Baumeister SHC and Nikiforow S and Driscoll T and Moskop A and McNerney KO and Phillips CL and Pulsipher MA and Hsieh EM and Rouce RH and Pasquini MC and Tiwari R and Willert J and Ramos R and Krueger J and Guest E and Grupp SA},
year = {2025},
journal = {Blood advances},
doi = {10.1182/bloodadvances.2025015881},
url = {https://doi.org/10.1182/bloodadvances.2025015881}
}RIS
TY - JOUR TI - Real-world data for tisagenlecleucel in patients with R/R B-ALL: subgroup analyses from the CIBMTR registry. AU - John S AU - Curran KJ AU - Hall EM AU - Keating AK AU - Baumeister SHC AU - Nikiforow S AU - Driscoll T AU - Moskop A AU - McNerney KO AU - Phillips CL AU - Pulsipher MA AU - Hsieh EM AU - Rouce RH AU - Pasquini MC AU - Tiwari R AU - Willert J AU - Ramos R AU - Krueger J AU - Guest E AU - Grupp SA PY - 2025 JO - Blood advances DO - 10.1182/bloodadvances.2025015881 UR - https://doi.org/10.1182/bloodadvances.2025015881 ER -
APA
S, J., KJ, C., EM, H., AK, K., SHC, B., S, N., T, D., A, M., KO, M., CL, P., MA, P., EM, H., RH, R., MC, P., R, T., J, W., R, R., J, K., E, G., & SA, G. (2025). Real-world data for tisagenlecleucel in patients with R/R B-ALL: subgroup analyses from the CIBMTR registry.. Blood advances. https://doi.org/10.1182/bloodadvances.2025015881
Source records
- pubmed · retrieved 2026-09-27T11:27:00.543Z